Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Endeavour Vision
AddedFeb 13, 2024
UpdatedJun 28, 2026
Endeavour Vision

Endeavour Vision

Operating

Endeavour Vision SA: A leading private equity firm investing in growth-stage medtech innovations.

Location
Geneva, Canton of Geneva, CH
Founded
2000
Firm
Compare
Portfolio
Employees
Website

Endeavour Vision is a leading private equity firm specializing in growth-stage medtech investments. The firm focuses on supporting companies with world-class technology and products in the medical technology sector. Endeavour Vision typically invests in Series B to Series E rounds, with occasional participation in earlier or later stages.

Notable portfolio companies include Gynesonics, IntelyCare, and Nalu Medical, each having raised over $150 million. The firm's investment philosophy centers on backing innovative medical technologies that have the potential to transform patient care. Endeavour Vision's expertise in the medtech sector allows them to provide valuable strategic guidance and industry connections to their portfolio companies, helping them navigate the complex healthcare landscape.

Endeavour Vision - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments25
Current Portfolio Count14
Total Portfolio Exits1

Top Investment Stages

Series B4 (21.1%)
Series C4 (21.1%)
Series D4 (21.1%)
Series Unknown4 (21.1%)
Series E3 (15.8%)

Stage Mix

Series B 21%Series C 21%Series D 21%Series Unknown 21%Series E 16%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Nalu Medical logo

Nalu Medical

Gynesonics logo

Gynesonics

Virtual Incision logo

Virtual Incision

Relievant Medsystems logo

Relievant Medsystems

Venture Med Group logo

Venture Med Group

Miach Orthopaedics logo

Miach Orthopaedics

HealthJoy logo

HealthJoy

IntelyCare logo

IntelyCare

Inbrace logo

Inbrace

Willow logo

Willow

Lumeon logo

Lumeon

Polares logo

Polares

Rapid Micro Biosystems logo

Rapid Micro Biosystems

Nuvaira logo

Nuvaira

EndoStim logo

EndoStim

Endeavour Vision - Similar Investment Firms

Endeavour Capital logo

Endeavour Capital

Visionary Venture Fund logo

Visionary Venture Fund

visionaryvc.com

Medingenii Capital logo

Medingenii Capital

medingenii.com

Endeavour Investments logo

Endeavour Investments

VisionTech Partners logo

VisionTech Partners

Engage Venture Partners logo

Engage Venture Partners

engagevp.com

Intuitive Ventures logo

Intuitive Ventures

Envision Ventures logo

Envision Ventures

envisionvc.com

ExSight Ventures logo

ExSight Ventures

Visionnaire Ventures logo

Visionnaire Ventures

visionnaire.vc

Envisage Equity logo

Envisage Equity

envisageequity.com

Endeavour Investment Partners logo

Endeavour Investment Partners

NextGen Ventures logo

NextGen Ventures

nextgenventures.nl

Evidity Health Capital logo

Evidity Health Capital

evidity.com

SightLine Partners logo

SightLine Partners

Endeavour Vision - Classification

Also Known As
  • Endeavour Vision SA
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end